Literature DB >> 16467600

Subcutaneous panniculitis-like T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A.

Yuka Tsukamoto1, Yoshioka Katsunobu, Yoko Omura, Isseki Maeda, Manabu Hirai, Hirofumi Teshima, Yoshio Konishi, Takeshi Inoue, Toshihiko Sato.   

Abstract

A case of subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is reported. A 27-year-old man presented with fever and abdominal swelling. His laboratory examination revealed pancytopenia and liver dysfunction. The diagnosis of SPTCL was made by biopsy based on thickened subcutaneous tissue. In addition, bone marrow specimen showed a hemophagocytosis syndrome (HPS). Methylprednisolone pulse therapy was initiated followed by prednisolone (60 mg/day) and cyclosporin A (150 mg/day). He responded to the treatment and remained asymptomatic for at least for 6 months. Our results suggest that a trial of cyclosporin A is warranted in patients with SPTCL complicated by HPS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467600     DOI: 10.2169/internalmedicine.45.1433

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.

Authors:  Dylan E Lee; M Estela Martinez-Escala; Linda M Serrano; Xiaolong A Zhou; Jason B Kaplan; Barbara Pro; Jaehyuk Choi; Joan Guitart
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

2.  Cyclosporine A as a Primary Treatment for Panniculitis-like T Cell Lymphoma: A Case with a Long-Term Remission.

Authors:  Won Sup Lee; Ji-Hyen Hwang; Moon Jin Kim; Se-Il Go; Anna Lee; Haa-Na Song; Min Jeong Lee; Myung Hee Kang; Hoon-Gu Kim; Jeong-Hee Lee
Journal:  Cancer Res Treat       Date:  2014-07-15       Impact factor: 4.679

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.